BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22121933)

  • 1. AQT cognitive speed and processing efficiency differentiate adults with and without ADHD: a preliminary study.
    Nielsen NP; Wiig EH
    Int J Psychiatry Clin Pract; 2011 Sep; 15(3):219-27. PubMed ID: 22121933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD.
    Nielsen NP; Wiig EH
    J Atten Disord; 2013 Apr; 17(3):187-93. PubMed ID: 22210798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.
    Nielsen NP; Wiig EH; Bäck S; Gustafsson J
    Nord J Psychiatry; 2017 May; 71(4):296-303. PubMed ID: 28413936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
    Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
    Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An additive model for relations between AQT single- and dual-dimension naming speed.
    Nielsen NP; Wiig EH
    Percept Mot Skills; 2011 Apr; 112(2):499-508. PubMed ID: 21667758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating depression and ADHD without depression in adults with processing-speed measures.
    Martiny K; Nielsen NP; Wiig EH
    Acta Neuropsychiatr; 2020 Oct; 32(5):237-246. PubMed ID: 32338233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?
    Boonstra AM; Kooij JJ; Oosterlaan J; Sergeant JA; Buitelaar JK
    J Clin Exp Neuropsychol; 2005 Apr; 27(3):278-98. PubMed ID: 15969353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate in ADHD adults on target evaluation processing reflected by event-related potentials.
    Ohlmeier MD; Prox V; Zhang Y; Zedler M; Ziegenbein M; Emrich HM; Dietrich DE
    Neurosci Lett; 2007 Sep; 424(3):149-54. PubMed ID: 17723273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quick test of cognitive speed for comparing processing speed to differentiate adult psychiatric referrals with and without attention-deficit/hyperactivity disorders.
    Wiig EH; Nielsen NP
    Prim Care Companion CNS Disord; 2012; 14(2):. PubMed ID: 22943032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise impact on sustained attention of ADHD children, methylphenidate effects.
    Medina JA; Netto TL; Muszkat M; Medina AC; Botter D; Orbetelli R; Scaramuzza LF; Sinnes EG; Vilela M; Miranda MC
    Atten Defic Hyperact Disord; 2010 Mar; 2(1):49-58. PubMed ID: 21432590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
    Brackenridge R; McKenzie K; Murray GC; Quigley A
    Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the association between stimulant treatment and cognitive outcomes across the life cycle of adults with attention-deficit/hyperactivity disorder: a controlled cross-sectional study.
    Biederman J; Fried R; Petty CR; Henin A; Wozniak J; Corkum L; Claudat K; Faraone SV
    J Nerv Ment Dis; 2012 Jan; 200(1):69-75. PubMed ID: 22210365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naming speed performance and stimulant effects indicate effortful, semantic processing deficits in attention-deficit/hyperactivity disorder.
    Tannock R; Martinussen R; Frijters J
    J Abnorm Child Psychol; 2000 Jun; 28(3):237-52. PubMed ID: 10885682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD).
    Snyder AM; Maruff P; Pietrzak RH; Cromer JR; Snyder PJ
    Child Neuropsychol; 2008 May; 14(3):211-26. PubMed ID: 17852127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between AQT processing speed and neuropsychological tests in neuropsychiatric patients.
    Nielsen NP; Ringström R; Wiig EH; Minthon L
    Am J Alzheimers Dis Other Demen; 2007; 22(3):202-10. PubMed ID: 17606529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.
    Low AM; Vangkilde S; le Sommer J; Fagerlund B; Glenthøj B; Jepsen JRM; Bundesen C; Petersen A; Habekost T
    Psychol Med; 2019 Nov; 49(15):2617-2625. PubMed ID: 30560740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.